资讯
22 小时
AZoLifeSciences on MSNVIRMA Protein Identified as Key Regulator of Ribosome Biogenesis in Brain DevelopmentRibosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...
2 小时
News-Medical.Net on MSNShift Bioscience proposes improved ranking system for virtual cell models to accelerate ...Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for ...
The Perturb-Multi method combines imaging and sequencing to study gene function in intact tissue. By analyzing liver tissue ...
Imagine that you want to know the plot of a movie, but you only have access to either the visuals or the sound. With visuals ...
The mRNA metabolism passively shapes the levels of an mRNA modification called m6A within a steady-state cell and upon stress.
Biopharma company AbbVie will acquire Capstan Therapeutics for up to $2.1 billion in cash, giving it access to promising new cell therapies that could treat autoimmune diseases like lupus.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果